Greater Occipital Nerve Block for Migraine Prophylaxis
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Migraine is a common neurological condition that can be disabling, particularly if chronic.
Greater occipital nerve (GON) block has been utilized for decades for the treatment of
migraine in the absence of a single randomized, placebo-controlled trial documenting its
effectiveness.
Hypothesis: Greater occipital nerve block reduces the frequency of days with moderate or
severe headache in patients with episodic or chronic migraine.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Center for Advancing Translational Science (NCATS)